$ASTH
Astrana Health, Inc.

2012 Q4 Form 10-Q Financial Statement

#000114420412068108 Filed on December 17, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q1 2011 Q4
Revenue $1.965M $1.500M $1.432M
YoY Change 37.23% 50.0% 43.2%
Cost Of Revenue $1.799M $1.100M $1.097M
YoY Change 63.97% 22.22% 21.9%
Gross Profit $166.2K $400.0K $334.8K
YoY Change -50.36% 300.0% 67.42%
Gross Profit Margin 8.46% 26.67% 23.38%
Selling, General & Admin $1.600M $700.0K $200.0K
YoY Change 700.0% 600.0% 0.0%
% of Gross Profit 962.72% 175.0% 59.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.048K $0.00 $3.941K
YoY Change 28.09%
% of Gross Profit 3.04% 0.0% 1.18%
Operating Expenses $1.603M $700.0K $208.6K
YoY Change 668.54% 600.0% 108.63%
Operating Profit -$1.437M -$300.0K $126.2K
YoY Change -1238.83% -1030792151040000000.0% 26.2%
Interest Expense $221.2K $0.00 $33.67K
YoY Change 557.04%
% of Operating Profit 26.68%
Other Income/Expense, Net -$3.284M -$100.0K -$68.00K
YoY Change 4729.81%
Pretax Income -$4.721M -$400.0K $58.20K
YoY Change -8211.82% 300.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.721M -$400.0K $58.20K
YoY Change -8211.82% 300.0%
Net Earnings / Revenue -240.26% -26.67% 4.06%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.424M -$133.3K $34.48K
COMMON SHARES
Basic Shares Outstanding 34.84M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q4 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.0K $200.0K $200.0K
YoY Change 150.0% -50.0% -60.0%
Cash & Equivalents $501.0K $164.4K $249.7K
Short-Term Investments
Other Short-Term Assets $200.0K $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses $62.65K $45.60K
Receivables $1.323M $994.1K $900.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.005M $1.249M $1.200M
YoY Change 67.11% 4.32% 0.0%
LONG-TERM ASSETS
Property, Plant & Equipment $41.94K $43.26K $0.00
YoY Change 100.35%
Goodwill $32.00K $32.00K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.450K $1.563K $0.00
YoY Change -100.0%
Total Long-Term Assets $162.0K $114.8K $700.0K
YoY Change -76.85% 89.3% 600.0%
TOTAL ASSETS
Total Short-Term Assets $2.005M $1.249M $1.200M
Total Long-Term Assets $162.0K $114.8K $700.0K
Total Assets $2.167M $1.364M $1.900M
YoY Change 14.07% 8.42% 46.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $192.1K $109.7K $0.00
YoY Change -100.0%
Accrued Expenses $400.0K $0.00 $100.0K
YoY Change 300.0% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $600.0K
YoY Change
Total Short-Term Liabilities $1.210M $1.515M $500.0K
YoY Change 141.93% 1533.8% 150.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.000M $200.0K $1.400M
YoY Change -28.57% -83.33% 16.67%
Other Long-Term Liabilities $0.00 $100.0K
YoY Change
Total Long-Term Liabilities $1.000M $300.0K $1.400M
YoY Change -28.57% -75.0% 16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.210M $1.515M $500.0K
Total Long-Term Liabilities $1.000M $300.0K $1.400M
Total Liabilities $2.246M $1.785M $2.100M
YoY Change 6.95% 33.1% 31.25%
SHAREHOLDERS EQUITY
Retained Earnings -$10.20M -$2.118M
YoY Change 51.55%
Common Stock $35.27K $29.34K
YoY Change 6.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$59.78K -$659.3K -$200.0K
YoY Change
Total Liabilities & Shareholders Equity $2.167M $1.364M $1.900M
YoY Change 14.07% 8.42% 46.15%

Cashflow Statement

Concept 2012 Q4 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$4.721M -$400.0K $58.20K
YoY Change -8211.82% 300.0%
Depreciation, Depletion And Amortization $5.048K $0.00 $3.941K
YoY Change 28.09%
Cash From Operating Activities $320.0K -$90.00K -$250.0K
YoY Change -228.0% 0.0% 733.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.00K
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K $0.00 $160.0K
YoY Change -93.75%
Cash From Investing Activities $10.00K $0.00 $160.0K
YoY Change -93.75% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -90.00K 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 320.0K -90.00K -250.0K
Cash From Investing Activities 10.00K 0.000 160.0K
Cash From Financing Activities -90.00K 0.000 0.000
Net Change In Cash 240.0K -90.00K -90.00K
YoY Change -366.67% -10.0% 200.0%
FREE CASH FLOW
Cash From Operating Activities $320.0K -$90.00K -$250.0K
Capital Expenditures $0.00 $0.00 -$10.00K
Free Cash Flow $320.0K -$90.00K -$240.0K
YoY Change -233.33% 28.57% 700.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Deferred Compensation Arrangement With Individual Shares Authorized For Issuance
DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance
3350000 shares
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34843441 shares
CY2009Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.11485
CY2009Q4 ameh Warrant Expiration Date
WarrantExpirationDate
2014-10-31
CY2009Q4 ameh Common Stock Warrants Term
CommonStockWarrantsTerm
P5Y
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
249653
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.11485
CY2012Q4 ameh Warrant Expiration Date
WarrantExpirationDate
2016-07-31
CY2012Q4 us-gaap Goodwill
Goodwill
32000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
272031
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
63000
CY2012Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
979
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1450
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2541669 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-59784
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
39200
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-78587
CY2012Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
27756
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
362746
CY2012Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
79432
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.18
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34768441 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2100000 shares
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
36047
CY2012Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
500000
CY2012Q4 us-gaap Liabilities
Liabilities
2245951
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
192148
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
62645
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28130
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5225000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
35269
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
35250
CY2012Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
18742
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10199290
CY2012Q4 us-gaap Assets
Assets
2167364
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.18
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1036288
CY2012Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
752
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1323261
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2167364
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
CY2012Q4 us-gaap Minority Interest
MinorityInterest
-18803
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500964
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34768441 shares
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
47446
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2608336 shares
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
627921
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1209663
CY2012Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1036288
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2005333
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.125
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
230096
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41935
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10795547
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.18
CY2012Q4 ameh Other Equity
OtherEquity
-691310
CY2012Q4 ameh Advances Current
AdvancesCurrent
11275
CY2012Q4 ameh Warrant Expiration Date
WarrantExpirationDate
2014-10-31
CY2012Q4 ameh Class Of Warrant Term
ClassOfWarrantTerm
P5Y
CY2012Q4 ameh Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedIntrinsicValue
CY2012Q4 ameh Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2100000 shares
CY2012Q4 ameh Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y4M24D
CY2012Q4 ameh Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
0.21299
CY2012Q4 ameh Class Of Warrant Or Right Outstanding Intrinsic Value Ending Balance
ClassOfWarrantOrRightOutstandingIntrinsicValueEndingBalance
CY2012Q4 ameh Common Stock Reserved For Future Issuance
CommonStockReservedForFutureIssuance
53577202 shares
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
397101
CY2012Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
120000
CY2012Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
596366
CY2012Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
150000
CY2012Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
4219
CY2011Q1 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
367500
CY2012Q1 us-gaap Goodwill
Goodwill
32000
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
258572
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90000
CY2012Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
11444
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1563
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
-659321
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38000
CY2012Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-421220
CY2012Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
5504
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
9609
CY2012Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
37500
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29335774 shares
CY2012Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
653026
CY2012Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1500000 shares
CY2012Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
27500
CY2012Q1 us-gaap Liabilities
Liabilities
1785268
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
109704
CY2012Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
45601
CY2012Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
12400
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2117708
CY2012Q1 us-gaap Assets
Assets
1364048
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
994118
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1364048
CY2012Q1 us-gaap Minority Interest
MinorityInterest
238101
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164361
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29335774 shares
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163476
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1515268
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42576
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1150000 shares
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
29336
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1000
CY2012Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
746366
CY2012Q1 us-gaap Assets Current
AssetsCurrent
1249224
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.11485
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
215311
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43261
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1429051
CY2012Q1 ameh Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liabilities Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitiesValue
773026
CY2012Q1 ameh Advances Current
AdvancesCurrent
2140
CY2012Q1 ameh Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
CY2012Q4 ameh Repurchase Of Common Stock Shares
RepurchaseOfCommonStockShares
500000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
-143780
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-164210
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
825
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
22092
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
367500
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5254
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Stock Issued1
StockIssued1
280000
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
25000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-302232
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
159074
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
53125
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
21999
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5136
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-147448
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
706312
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2595
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
185444
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-291159
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4290
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13244
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
154290
us-gaap Operating Expenses
OperatingExpenses
716126
us-gaap Cost Of Services
CostOfServices
2993020
us-gaap Adjustment For Amortization
AdjustmentForAmortization
28125
us-gaap Revenues
Revenues
3565366
us-gaap Depreciation
Depreciation
9814
us-gaap Gross Profit
GrossProfit
572346
us-gaap Interest Paid
InterestPaid
63599
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28992367 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
603
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
63000
us-gaap Net Income Loss
NetIncomeLoss
-293559
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-147379
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400
us-gaap Interest Expense
InterestExpense
96849
us-gaap Increase Decrease In Due To Officers And Stockholders Current
IncreaseDecreaseInDueToOfficersAndStockholdersCurrent
14953
ameh Number Of Customers
NumberOfCustomers
3 Customer
dei Trading Symbol
TradingSymbol
AMEH
dei Entity Registrant Name
EntityRegistrantName
APOLLO MEDICAL HOLDINGS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-10-31
dei Entity Central Index Key
EntityCentralIndexKey
0001083446
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Reclassification</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">Certain amounts in the 2011 condensed consolidated financial statements have been reclassified to conform them to the 2012 presentation.</p> </div>
us-gaap Operating Income Loss
OperatingIncomeLoss
-1553404
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y4M24D
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-14114
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
5771
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y4M24D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.19
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
441477
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37493
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>Concentrations</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The Company had three major customers during the three month period ended October 31, 2012 which contributed 20.8%, 6.3% and 4.2% of revenue, respectively, and during the three month period ended October 31, 2011 which contributed 30.2 %, 10.3 % and 6.1% of revenue, respectively.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The Company had three major customers during the nine month period ended October 31, 2012 which contributed 24.0%, 7.7% and 4.9% of revenue, respectively, and during the nine month period ended October 31, 2011 which contributed 36.9 %, 19.1% and 7.9 %, of revenue, respectively.</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Receivables from these customers amounted to 9.7 %, 9.4%, and 5.5% of total accounts receivable at October 31, 2012, respectively, and 14.1%, 9.0% and 4.2% of total accounts receivable as of January 31, 2012, respectively.</p> </div>
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
5853855
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
205948
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
655
us-gaap Income Taxes Paid
IncomeTaxesPaid
9040
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
61671
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
509948
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13459
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
336603
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2451778
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1450
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
657
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
252755
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8076783
us-gaap Nature Of Operations
NatureOfOperations
<div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.25in"><b>1.</b></td> <td style="TEXT-ALIGN: justify"><b>Description of Business</b></td> </tr> </table> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">Apollo Medical Holdings, Inc. (&#x201C;Apollo&#x201D; or the &#x201C;Company&#x201D;) is a leading provider of hospitalist services in Los Angeles, California area. Hospitalist medicine is organized around the admission and care of patients in an inpatient facility such as a hospital or skilled nursing facility and is focused on providing, managing and coordinating the care of hospitalized patients. Apollo operates as a medical management holding company that focuses on managing the provision of hospital-based medicine through the following wholly-owned subsidiary management companies, Apollo Medical Management, Inc. (&#x201C;AMM&#x201D;), Pulmonary Critical Care Management, Inc. (&#x201C;PCCM&#x201D;), Verdugo Medical Management, Inc. (&#x201C;VMM&#x201D;) and ApolloMed Accountable Care Organization, Inc. (&#x201C;ApolloMed ACO&#x201D;). Through AMM, PCCM, and VMM, the Company manages affiliated medical groups, which consists of ApolloMed Hospitalists (&#x201C;AMH"), Los Angeles Lung Center (&#x201C;LALC&#x201D;) and a pulmonary medical practice ("Verdugo"). AMM, PCCM and VMM each operate as a physician practice management company (&#x201C;PPM&#x201D;) and are in the business of providing management services to physician practice companies (&#x201C;PPC&#x201D; &#x2018;s) under long-term management service agreements.&#xA0;</p> <p style="TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">On July 10, 2012, ApolloMed ACO was notified that it had been selected by the Centers for Medicare and Medicaid Services (&#x201C;CMS&#x201D;) to participate in the Medicare Shared Savings Program (&#x201C;MSSP&#x201D;). The Medicare Shared Savings Program model is designed to encourage the development of Accountable Care Organizations (&#x201C;ACOs&#x201D;), which can be comprised of hospitals, doctors and other health care providers who work together and are accountable for quality outcomes and the overall patient experience, while reducing the growth in Medicare expenditures. Through the MSSP model, ApolloMedACO will work with CMS on a program for Medicare beneficiaries to enhance the engagement between patients and their medical providers through the coordination of care and services across all aspects of their healthcare needs. The goal of the program is to improve the quality of the patient&#x2019;s care and outcomes through more efficient and coordinated approach among providers.</p> </div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
130000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
35790
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
370000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Operating Expenses
OperatingExpenses
2466563
us-gaap Cost Of Services
CostOfServices
4333289
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Adjustment For Amortization
AdjustmentForAmortization
61671
us-gaap Revenues
Revenues
5246448
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
370000
us-gaap Depreciation
Depreciation
14785
us-gaap Gross Profit
GrossProfit
913159
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6523379
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
500000
us-gaap Interest Paid
InterestPaid
15000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31673682 shares
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
490374
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
113096
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1222353
us-gaap Net Income Loss
NetIncomeLoss
-8081583
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
4075000 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4800
us-gaap Use Of Estimates
UseOfEstimates
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"><b>Use of Estimates</b></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.</p> </div>
us-gaap Increase Decrease In Due To Officers And Stockholders Current
IncreaseDecreaseInDueToOfficersAndStockholdersCurrent
6342
us-gaap Interest Expense
InterestExpense
608510
ameh Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset And Liabilities Other
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAndLiabilitiesOther
6626881
ameh Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
144485
ameh Deferred Costs Period Increase Decrease
DeferredCostsPeriodIncreaseDecrease
-55000
ameh Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-5853855
ameh Reclassification Of Warrant Liabilities To Equity
ReclassificationOfWarrantLiabilitiesToEquity
6626881
ameh Issuance Of Common Stock Value For Stock Based Compensation
IssuanceOfCommonStockValueForStockBasedCompensation
691310
ameh Number Of Warrants Exercised
NumberOfWarrantsExercised
shares
ameh Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
1500000 shares
ameh Number Of Customers
NumberOfCustomers
3 Customer
ameh Service Agreement Term
ServiceAgreementTerm
P20Y
ameh Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
2100000 shares
CY2012Q1 ameh Increase Decrease In Fair Value Of Contingent Consideration
IncreaseDecreaseInFairValueOfContingentConsideration
-367500
ameh Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset And Liabilities Derivative Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAndLiabilitiesDerivativeAdjustment
-5853855
ameh Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue
ameh Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
ameh Number Of Warrants Granted
NumberOfWarrantsGranted
2100000 shares
ameh Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue
ameh Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Additions
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAdditions
ameh Common Shares Issued And Outstanding
CommonSharesIssuedAndOutstanding
34768441 shares
ameh Class Of Warrant Or Right Outstanding Intrinsic Value Beginning Balance
ClassOfWarrantOrRightOutstandingIntrinsicValueBeginningBalance
ameh Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm
P9Y8M12D
ameh Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Exercise Of Derivative Warrants
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityExerciseOfDerivativeWarrants
ameh Class Of Warrant Or Rights Grant In Period Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsGrantInPeriodWeightedAverageRemainingContractualTerm
P3Y9M26D
ameh Class Of Warrant Or Right Granted Intrinsic Value
ClassOfWarrantOrRightGrantedIntrinsicValue
ameh Warrants Issued In Connection With Notes Payable
WarrantsIssuedInConnectionWithNotesPayable
200452
CY2009Q4 ameh Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
1500000 shares
CY2012Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
50000
CY2012Q4 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
100000 shares
CY2012Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
210000
CY2012 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
600000 shares
CY2012Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200000 shares
CY2012Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
20776
CY2012Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1598373
CY2012Q2 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
216000 shares
CY2012Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
400000 shares
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
90000
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
126202
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2011Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
34375
CY2011Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
204690
CY2011Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
49
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
58204
CY2011Q4 us-gaap Operating Expenses
OperatingExpenses
208631
CY2011Q4 us-gaap Cost Of Services
CostOfServices
1097132
CY2011Q4 us-gaap Revenues
Revenues
1431965
CY2011Q4 us-gaap Depreciation
Depreciation
3941
CY2011Q4 us-gaap Gross Profit
GrossProfit
334833
CY2011Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29331970 shares
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
58204
CY2011Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-67998
CY2011Q4 us-gaap Interest Expense
InterestExpense
33672
CY2011Q4 ameh Number Of Customers
NumberOfCustomers
3 Customer
CY2012Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
300000 shares
CY2012Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
41560
CY2012Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
25661
CY2012Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1437225
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2012Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
207
CY2012Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4721401
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
1603421
CY2012Q4 us-gaap Cost Of Services
CostOfServices
1798957
CY2012Q4 us-gaap Revenues
Revenues
1965153
CY2012Q4 us-gaap Depreciation
Depreciation
5048
CY2012Q4 us-gaap Gross Profit
GrossProfit
166196
CY2012Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33440542 shares
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-4721401
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3284176
CY2012Q4 us-gaap Interest Expense
InterestExpense
200463
CY2012Q4 ameh Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-3063144
CY2012Q4 ameh Number Of Customers
NumberOfCustomers
3 Customer

Files In Submission

Name View Source Status
0001144204-12-068108-index-headers.html Edgar Link pending
0001144204-12-068108-index.html Edgar Link pending
0001144204-12-068108.txt Edgar Link pending
0001144204-12-068108-xbrl.zip Edgar Link pending
ameh-20121031.xml Edgar Link completed
ameh-20121031.xsd Edgar Link pending
ameh-20121031_cal.xml Edgar Link unprocessable
ameh-20121031_def.xml Edgar Link unprocessable
ameh-20121031_lab.xml Edgar Link unprocessable
ameh-20121031_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v330006_10q.htm Edgar Link pending
v330006_ex31-1.htm Edgar Link pending
v330006_ex31-2.htm Edgar Link pending
v330006_ex32-1.htm Edgar Link pending
v330006_ex32-2.htm Edgar Link pending
v330006_ex4-3.htm Edgar Link pending
v330006_ex4-4.htm Edgar Link pending
v330006_ex4-5.htm Edgar Link pending